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Abstract Although various regimes are available, some are specific to cycling mares during the 
ovulatory season and noncycling mares during anovulatory or transitional season and early postpartum .In this 
regard this paper discusses and summarizes the basis for the use of some regimens for controlling ovulation in 
the mare. 
 
For controlling the estrous cycle of the cycling mare there are some conventional 
regimens and novel methods. Before beginning any regimen with the help of ultrasonography 
or transrectal palpation the reproductive tract should be assessed and then a decision about 
when to use one regimen over another can be taken. The most common hormonal treatments 
used in the regimens are presented below. 
The natural form of PgF2α and some of its analogues have been used in mares to 
induce luteal regression and hasten estrous and ovulation. Treatment with native PgF2α 
(dinoprost, 5-10 mg/dose36) may induce some undesirable side effects , that’s why  analogues 
(cloprostenol ,100-250µg/dose36; luprostiol 7,5 mg/dose3 ) that produce less side effects but 
with a potent luteolytic action are sometimes preferred .Treatment with PgF2α can be done by 
any parentheral routes , but the most common used is the intramuscular injection. A recent 
study involved administration of PgF2α at one-tenth the conventional dose (dinoprost ,0.5 mg) 
into the sacral-lumbar space at mid-diestrus1.Results indicated a significant and sustained 
decrease in systemic levels of progesterone 24 hours after the sacral-lumbar injection, witch 
was similar to the changes obtained in mares that received the conventional dose 
intramuscular.  
A regimen for the induction of ovulation consists in a PgF2α injection (day1) followed 
by an hCG treatment (day 7-8) and another PgF2α administration (day 15) followed by hCG 
treatment (day 21-22).The interval between the end of the treatment and the ovulation time is 
of 2-4 days17 
The concept of using progestogen treatment during the estrous cycle is to prolong or 
extend the cycle by inducing an artificial progestational phase after spontaneous or induced 
regression of the corpus luteum .Progesterone has a negative feed-back effect on luteinizing 
hormone (LH) secretion from the anterior pituitary gland. Progestogen suppresses LH to 
levels that are inadequate to cause ovulation.  
A regimen available consist in giving progesterone ( 150 mg/dose3) or altrenogest 
daily for 8 to 12 days  and to give PgF2α at the end of progesterone treatment to ensure the 
regression of primary or secondary corpus luteum. PRID-Spirals or CIDR-B-Sponge can also 
be used intravaginal for 8 days3. Estrus may be expected within 2 to 5 days, or hCG can be 
used to reduce the interval to ovulation. Since this regimen does not control the follicular 
development estrogen can be used as a potent inhibitor to control follicular development to 
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further ovulation synchrony. Common regimen involves the combined intramuscular injection 
of progesterone (150 mg) and estradiol (10 mg) for 10 days, beginning at random stages of the 
estrous cycle25. Treatment with PgF2α is given on the last day of steroid treatment .The results 
attested that a high degree of ovulation synchrony (81%) occurred between 10 to 12 days after 
PgF2α treatment. This regimen has also been used with hCG when the diameter of the largest 
follicle reached >35 mm to ensure a more predictable ovulation38. 
Follicle ablation combined with PgF2α and hCG treatments can be used as an 
alternative approach 40. Four days after ablation and aspiration  of all follicles greater than 10 
mm in diameter luteal regression can be induced with PgF2α  (cloprostenol 250 µg/dose) 
given twice ,12 hours apart. The 4 days interval is necessary for the luteinisation of the corpus 
lutea and the remaining tissue after abaltion. Finnaly hCG (1500 UI) is given when the largest 
follicle is greater than 30 mm .The results indicated development of a new group of follicles 
in 1-3 days after abaltion.96% of the mares ovulated within 48 hours after hCG treatments. 
The interval from the start of the regimen (the follicular ablation) to the ovulation was of 10-
14 days with 50 % shorter than with conventional regimen of using progesterone or 
progesterone plus estradiol 40. 
Human chorionic gonadotropin (hCG) has been used for over 40 years for induction of 
ovulation in mares and is one of the most commonly administrated hormones for equine 
reproduction management10. hCG can by used to shorten the interval from estrus to ovulation. 
There is no standard dose of hCG used to induce ovulation; a single dose can range from 1000 
to more than 6000 UI36 (1500 to 5000 UI 3).Typically the treatment with hCG is done when 
the largest follicle reaches al least 35 mm in diameter during estrus. In 80% of mares 
ovulation occurs within 48 hours15.Administration of 1500-330 UI of hCG to mares on or 
after their second day of estrus will cause > 80 % to ovulate within 48 hours23, 21, 8.  
With hCG use there is always a potential of antibody production stimulation because 
hCG is a foreign protein to the mare 36 . In one study 40 mares continued to ovulate, maintain 
pregnancy and foal in the presence of high hCG antibodies .It was also noted that mares with 
high antibody titers still ovulated spontaneously because the antibodies did not react with 
equine luteinizing hormone (LH) 2. Because of the potential decrease in efficacy with repeated 
use it is recommended to use hCG not more than once or twice during a breeding season 5,25,38 
.If a timed ovulation is required for additional estrous cycle it is recommended that an 
alternative ovulation –inducing agent such as deslorelin acetate be used 25. 
A convenient and efficacious alternative agent  to hCG with the advantages of 
avoiding hCG imunogenicity and hasten ovulation during estrus is represented by GnRH. 
Native GnRH (gonadorelin,2-5 mg/dose) or analogues of GnRH (buserelin, 20-40 µg/dose) 
have been given to mare in estrus when the size of the largest follicle is greater as 30 
mm10,22.Buserelin 20  µg I.V every 12 hours induces the ovulation in 24-48 hours in 60-90% 
of the mares with at least a 35 mm follicle 13 .Recently a biodegradable short-tern implant  
(Ovuplant) containing the GnRH analogue deslorelin 2.2 mg has become commercially 
available  for use in mares (USA,Australia,Canada).Studies 19,32 have indicated that when the 
implant is put in place ( by a single injection , under the skin of the neck) when diameter of 
the largest follicle in greater than 30 mm a high percentage of mares (>80%) ovulate within 
48 hours. 
For inducing or hastening ovulation of the noncycling mare the most common 
regimens are presented below. 
Hastening the first ovulation of the season is most practically accomplished by 
artificially controlling of the daylight period. A common lighting regimen is to provide 16 
hours oh light and 8 hours of dark; however shorter periods of light (14.5 hours) may also be 
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effective22, 15, 29 Light can be supplemented in the afternoon and evening to give a total of 16 
hours light each day. A dark period should not interrupt the transition from daylight to 
supplemental light and the lighting program should be consistently followed each day. The 
light should be bright enough for you to read the small print of a newspaper throughout the 
mare's housing area. The average time from the start of the typical lighting regimen (200 Watt 
/Box) 3 to the first ovulation has been between 60 and 80 days. In this regard starting the light 
regimen between November 15 and December 1 results in the onset of the ovulatory season 
around 15 February. The same thing can be done in the end of the ovulatory season for the 
extension with 1-2 months of the ovulatory season into the fall by providing the same 16 
hours of light regimen 15 
The efficacy of progestogen treatment alone for hastening the ovulatory season in 
transitional mares is equivocal36.It has been suggested that prolonged progestogen treatment 
can inhibit pituitary release of LH so that at the end of the treatment an accumulation occurs 
and the systemic levels. This will be sufficient to stimulate follicle maturation and ovulation. 
It appears that progestogen treatment alone can synchronize the first ovulation of the year, 
especially when mares are in the transitional period with large ovarian follicles (>20 mm )36,3 
.Progesterone can be administrated as an oily-based intramuscular injection ,orally as a 
synthetic progestogen (Altrenogest-EquineRegumate) or by using a silastic progesterone-
realizing intravaginal device35.One regimen is to administer progestogen  (progesterone 150 
mg/day or altrenogest 0.44 mg/kg/day) for 10-15 days when the largest follicle is at least 20 
mm29,31.Ovulation may occur in about 12 days after cessation of treatment.  
Another regimen has been to expose anestrous mares to control lighting for 60 days 
before the start of the progestogen treatment and to administer hCG on the second day of 
estrus 29 .A PRID-Spiral (Progesterone Releasing Intravaginal Device) or a CIDR-Sponge 
(Controlled Internal Drug Releasing Device) can be administrated intravaginal for 12 to 14 
days, followed by a PgF2α treatment and than 3000 UI hCG, when the biggest follicle is >35 
mm.The ovulation can occur in 20 days 3  from the begining of the treatment. 
hCG alone can be used to induce or to hasten the first ovulation9. In one study 9a 
intravenous injection of hCG (3300 UI) was given when the largest follicle attained 40 mm 
diameter and behavioral estrus was displayed for at least 3 days during the transitional period. 
Results indicated that 89% of the mares ovulated in 1 to 6 days after hCG treatment .It 
appears that hCG can be used alone to hasten or ensure ovulation in late-transitional mares 
when diameter of the largest follicle is greater than 30 mm and characteristic signs of estrus 
are displayed for several days11 .Administration of higher doses will normally produce a more 
rapid effect, although doses over 4500 UI are associated with ovulation but lower pregnancy 
rate 14 
GnRH has been use not only in cycling mares but also in noncycling mares to induce 
ovulation in “deep anestrous” mares and to hasten ovulation in transitional mares. There is a 
limited data available in witch the clinicians claim a success treatment with repeated 
implantation of GnRH superagonists such as deslorelin, or repeated administration of GnRH 
agonists such as buserelin.There have been some discussion of subsequent prolonged luteal 
phase in mare treated with deslorelin 14 . 
Numerous studies have indicated that administration of GnRH in a frequent (pulsatile) 
intermittent (once every 12 hours) , or continues manner stimulated follicular growth , 
maturation and ovulation in anestrous mares 36 .The duration of the treatment , the percentage 
of mares ovulating in a defined time, and subsequent maintenance of pregnancy are all related 
to the degree of follicular development at the start of the treatment 15,31 .The most common 
method of delivering GnRH is by intramuscular or subcutaneous injections twice daily for 
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about 2 to 3 weeks or until the first ovulation of the year. With the use of a GnRH analogue 
(buserelin) to transitional mares in February, subcutaneous injections of 10-40 µg every 12 
hours for 21-28 days or until ovulation have resulted in 47% to 78% of the mares ovulating 
within 3 weeks from the start of the treatment 18, 26 
Although artificial control of photoperiod is probably still the most efficient 
nonhormonal method for hastening the ovulatory season, other factors along the neural-
hormonal pathway, apart GnRH, may provide alternative methods for controlling the length of 
seasonal anestrus.Dopamine antagonists can hasten the ovulatory season in mares trough the 
inverse relationship between prolactin and dopamin in the mare. The systemic levels of 
prolactin are low during anovulatory season and cerebrospinal fluid levels of dopamine high 30 
.When a dopamine receptor blocker was given to mares during the anovulatory season, 
circulating concentrations of prolactin increased in association with increased follicular 
growth 34.The mechanism by witch the dopamine-prolactin interaction exerts its effect at the 
level of the ovary is unknown. Investigators have examined the potential of using dopamine 
D-2 antagonists as an alternative hormonal method of hastening the ovulatory season. 
Domperidone and sulpiride are two antagonists of dopamine with a low prevalence of 
side effects that have been recently evaluated (are not licensed for use in the mare) 14. In 
separated studies7 anestrous mares were treated daily with intramuscular injections of either 
domperidone (1.1mg/kg) or sulpiride (200 mg/mare36) beginning from middle January –to the 
first days of February for 55-58 days, or until the first ovulation. The first ovulation in the 
season occurred in  27-41 days from the beginning of the treatment36  (12-24 
days14).Consequently the ovulatory season can be hastened by as much as 2.5 month with 
dopamine D-2 antagonists. Sulpiride can be administrated in a dose of 0, 5 mg/ kg 3 . 
A poor management of breeding can be one of the most important causes of 
reproductive inefficiency in the horse. Most of the problems result from a failure to appreciate 
either the seasonal nature of reproduction in the horse, or the fact that mares have a variable 
estrous cycle pattern even during the ovulatory season. A thorough understanding of the 
breeding management and careful attention to the specific treatments and regimes for a 
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